| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 07/19/2001 | WO2000046351A3 Platform for the differentiation of cells |
| 07/19/2001 | WO2000031136A9 Antagonistic analogs of gh-rh inhibiting igf-i and -ii |
| 07/19/2001 | DE19961219A1 11beta-Phenylestratrien-Derivate mit Fluoralkylgruppen in der aromatischen Seitenkette, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 11beta-Phenylestratrien derivatives with fluoroalkyl groups in the aromatic side chain, their preparation and pharmaceutical compositions containing them |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397030A1 Methods for treating pancreatic disorders |
| 07/19/2001 | CA2396962A1 Benzosulfones and related compositions and methods |
| 07/19/2001 | CA2396247A1 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | CA2396098A1 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/19/2001 | CA2383158A1 Use of a cyclic ether for the preparation of medicaments affecting glucose tolerance |
| 07/18/2001 | EP1116516A1 Templating of solid particles by polymer multilayers |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115866A1 Cystine knot growth factor mutants |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115721A1 Pyrimidone derivatives |
| 07/18/2001 | EP1115398A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 07/18/2001 | EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 07/18/2001 | EP0754048B1 Treatment of partial growth hormone insensitivity syndrome |
| 07/18/2001 | CN1304450A Novel insulin analogs with enhanced zinc binding |
| 07/18/2001 | CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 07/18/2001 | CN1068583C N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
| 07/18/2001 | CA2332169A1 Treatments for obesity and methods for identifiying compounds useful for treating obesity |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
| 07/17/2001 | US6262118 Therapy of type 2 diabetes in a mammal by administering (-) 4-chlorophenyl-(3-trifluoromethylphenoxy)acetic acid derivative |
| 07/17/2001 | US6262104 Selective delta opioid agonists and antagonists |
| 07/17/2001 | US6262098 Estrogen receptor modulators |
| 07/17/2001 | US6262042 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/17/2001 | US6261572 In situ administering |
| 07/17/2001 | CA2130515C New 11-benzaldoxime-17.beta.-methoxy-17.alpha.-methoxymethylestradiene derivatives, methods for their production and pharmaceuticals containing these substances |
| 07/12/2001 | WO2001049866A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 07/12/2001 | WO2001049838A2 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region |
| 07/12/2001 | WO2001049682A1 Condensed azepines as vasopressin agonists |
| 07/12/2001 | WO2001049673A2 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | WO2001049294A1 Product for treating gynecomastia |
| 07/12/2001 | WO2001049264A2 Pharmaceutical compositions for oral administration |
| 07/12/2001 | WO2001049163A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | US20010007875 Antidiabetic agents |
| 07/12/2001 | US20010007656 Introducing cells treated in vivo with DNA segment comprising transcription factor gene (c-Myc) and operably linked promoter sequence to patient |
| 07/12/2001 | DE19963859A1 Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen Bi- or oligomer of a di-, tri-, Quattro or pentamer of recombinant fusion proteins |
| 07/12/2001 | CA2396379A1 Pharmaceutical compositions for oral administration |
| 07/12/2001 | CA2396059A1 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | CA2394721A1 Product for treating gynecomastia |
| 07/12/2001 | CA2331059A1 Method of reducing morbidity and the risk of mortality |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1114053A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 07/11/2001 | EP1114051A1 INHIBITORS OF p38 |
| 07/11/2001 | CN1303391A 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/11/2001 | CN1303389A 3',3'-N-substituted macrolide LHRH antagonists |
| 07/11/2001 | CN1303368A 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof |
| 07/11/2001 | CN1302665A Medicine for treating thyroidism accompanied by infiltrative exorbitism |
| 07/11/2001 | CN1068324C Crystalline substituted benzothiophene hydrochlorate, pharmaceutical preparation and its use |
| 07/11/2001 | CN1068228C Medicine for reducing pathologic raised beta-receptor and its producing technology |
| 07/11/2001 | CN1068206C Traditional Chinese medicine for adrenocortical hormone adverse reaction and compound preparation thereof |
| 07/10/2001 | WO2001051056A1 Fulvestrant formulation |
| 07/10/2001 | US6258826 Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome |
| 07/10/2001 | US6258578 His5 |
| 07/10/2001 | US6258557 Nucleotide sequences associated with preferential gene expression; for the treatment of vascular injury; for reducing or preventing the development of arteriosclerosis |
| 07/10/2001 | US6258341 Drug dispersion for oral inhalation and pulmonary absorption |
| 07/10/2001 | CA2214629C Receptor activation by gas6 |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047915A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047892A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | WO2001047880A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047875A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 07/05/2001 | WO2001047859A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | WO2001047562A2 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 07/05/2001 | WO2001047531A1 Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity |
| 07/05/2001 | WO2001047514A1 Use of hypoglycemic agent for treating impaired glucose metabolism |
| 07/05/2001 | WO2001047490A1 Devices for the delivery of drugs having antiprogestinic properties |
| 07/05/2001 | WO2000074650A3 Implantable gel compositions and method of manufacture |
| 07/05/2001 | WO2000061622A3 Genes associated with diseases of the kidney |
| 07/05/2001 | WO2000055137A8 Compounds and methods for modulation of estrogen receptors |
| 07/05/2001 | WO1999053910A8 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 07/05/2001 | US20010006790 Ihhibition of amylin release |
| 07/05/2001 | CA2396579A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | CA2395716A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 07/05/2001 | CA2395543A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395236A1 Basolateral sorting signal and inhibitors thereof |
| 07/05/2001 | CA2393583A1 Compounds active at the glucocorticoid receptor |
| 07/04/2001 | EP1113015A1 Optically active 3-((2-piperazinyl-phenyl)methyl)-1-(4-(trifluoromethyl)-phenyl)-2-pyrrolidinone compounds as 5-HT1D receptor selective antagonists |
| 07/04/2001 | EP1113013A1 Benzothiophene compounds, intermediates, compositions and methods |
| 07/04/2001 | EP1113007A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 07/04/2001 | EP1112364A2 Stomach polypeptide zsig28 |
| 07/04/2001 | EP1112275A1 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 07/04/2001 | EP1112251A1 Azetidine derivatives, preparation and medicines containing them |
| 07/04/2001 | EP1112062A1 Mousse composition |
| 07/04/2001 | EP0736038B1 Compounds with growth hormone releasing properties |
| 07/04/2001 | EP0666746B1 $g(D)5-ANDROSTENES USEFUL FOR PROMOTING WEIGHT MAINTENANCE OR WEIGHT LOSS AND TREATMENT PROCESS |
| 07/04/2001 | CN1067875C Estradiol weekly-acting percutaneous absorption adhesive plaster |
| 07/03/2001 | US6255351 Treatment of bone disorders |
| 07/03/2001 | US6255310 Psychological disorders; antidepressants |
| 07/03/2001 | US6255289 Gene delivery by secretory gland expression |
| 07/03/2001 | CA2012115C Iodinated somatostatins |
| 06/29/2001 | CA2329576A1 Optically active 3-[(2-piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-ht1d receptor selective antagonists |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046196A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |